longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

BioNexus Gene Lab

BGLC

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -1.64, above the reasonable range, cheaper than 6.65% of the time in the past 3 years, and the industry ranks 42/56, the industry Median 17.82.

-1.64xP/E
$1.44Stock price
$-0.88Earnings per share
-1.64xP/E
Stock price$1.44Earnings per share$-0.88

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-3.26x
Typical range
-4.42x–-2.34x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 17.82x
06121824

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 17.82x
0x30x60x90x120x150x
P/E ratio
Name/Symbol
QXOUSQXO
-18.08x12.70%$11.87B
XMTRUSXometry
-162.95x85.53%$5.02B
DNOWUSDNOW
-15.48x80.70%$2.91B
BXCUSBluelinx
-310.21x4,600.00%$604.29M
TITNUSTitan Machinery
-10.07x32.77%$571.14M
ZKHUSZKH
-1,099.41x164.00%$462.49M
ALTGUSAlta Equipment
-2.27x48.82%$188.81M
NPTUSTexxon
-22.98x--$64.34M
SPPLUSSimpple
-7.18x--$23.19M
FGIUSFGI Industries
-4.86x77.50%$19.22M
MWYNUSMarwynn
-14.50x--$18.99M
OPTIUSOptec International, Inc.
----$8.07M
MWGUSMulti Ways
-15.44x--$6.68M
BGLCUSBioNexus Gene Lab
-1.64x--$4.22M
CAPSUSCapstone
-0.16x104.85%$3.47M
IPWUSiPower
-0.31x--$2.52M
LVROFUSLAVORO LIMITED
-0.00x--$114.97K
MKDTYUSMolecular Data Inc.
----$1.22K

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.